Pharmaceutical Company Declares Highest-Ever Cash Dividend Payout
Hai Phong Pharmaceutical (DPH) announces 20% interim dividend for 2025, with an estimated total expenditure of approximately VND 6 billion.
Hai Phong Pharmaceutical Joint Stock Company (stock code: DPH) has announced its plan to pay a cash dividend for the 2025 financial year.
According to the announcement, the record date for final shareholder registration is January 6, with the payment date scheduled for January 20, 2026. The distribution rate is set at 20% per share, equivalent to VND 2,000 per share. It is estimated that the company will allocate about VND 6 billion for this payment round.
This interim dividend rate aligns with the plan approved at the 2025 Annual General Meeting of Shareholders and represents the highest payout ratio in DPH’s operating history.
DPH has consistently paid cash dividends to its shareholders between 2017 and 2025. In the two most recent years (2024 and 2025), the payment rate was 17%, while in 2020, 2022, and 2023, the rate was 15% annually.
On the stock market, DPH’s share price closed the session on December 15 unchanged at the reference price of VND 43,100 per share due to a lack of transactions. This price level is the lowest in over a year for the company, reflecting a 35% drop from its historical peak of VND 66,000 recorded in July 2025.
The liquidity of DPH’s shares is generally low, suggesting a relatively concentrated shareholder structure. The largest shareholders include Mr. Tran Van Huyen, General Director and Vice Chairman of the Board of Directors, who holds 57.72% of the charter capital; Hai Phong Pharmaceutical Co., Ltd. owns 11.67%; and Mr. Le Ngoc Duc holds 6.48%.
